Skip to main content
Clinical Trials/NCT03869450
NCT03869450
Completed
Not Applicable

A Multi-center, Evaluator-blinded Study to Evaluate Effectiveness and Safety of HA Fillers for Lifting, Contouring and Correcting Volume Deficiency of the Midface Using an Individualized Treatment Algorithm

Galderma R&D1 site in 1 country90 target enrollmentNovember 9, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Volume Deficiency of the Midface
Sponsor
Galderma R&D
Enrollment
90
Locations
1
Primary Endpoint
Percentage of Participants With Aesthetic Improvement of Midface
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of participant tissue coverage and main treatment goal (volumizing, lifting or contouring).

Registry
clinicaltrials.gov
Start Date
November 9, 2018
End Date
August 30, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male/Female 25 to 55 years old that needs lifting, contouring or volumization of the midface
  • Signed and dated informed consent

Exclusion Criteria

  • Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel and lidocain
  • Previous use of any permanent or semi-permanent facial tissue augmentation therapy or contouring with, lifting threads, permanent implants, or autologous fat in the treatment area
  • Previous use of any HA or collagen based facial tissue augmentation therapy in the facial area, any previous use of neurotoxin or any previous facial surgery
  • Any medical condition that in the opinion of the Investigator would make the participant unsuitable for inclusion

Outcomes

Primary Outcomes

Percentage of Participants With Aesthetic Improvement of Midface

Time Frame: 8 weeks

A blinded evaluator assesses the improvement compared to baseline (pre-treatment) using a 5-graded scale; Worse, No change, Improved, Much improved or Very much improved. Aesthetic improvement of midface is defined as those participants assessed as Improved, Much improved or Very much improved.

Secondary Outcomes

  • Percentage of Participants With Improved Midface Volume(8 weeks)
  • Percentage of Participants Assessed as Having Natural Treatment Results(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials